Angiotensin Receptor Blockers – Olmesartan

Generic Name		olmesartan, including in combination with hydrochlorothiazide
Form		20 mg, 40 mg, 20 mg/12.5 mg, 40 mg/12.5 mg, 40 mg/25 mg
Form		tablet

Criteria

Approval Period

1. Person identified as experiencing intractable cough or angioedema on an Angiotensin Converting Enzyme Inhibitor (ACE-I).

AND

2. Failure on optimal doses of, or intolerance to, ALL reference drugs: candesartan, losartan, telmisartan AND valsartan.

Indefinite

Practitioner Exemptions

Individuals requiring a diuretic combination product must satisfy the same criteria.